Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women. Bouligand, J.; Cabaret, O.; Canonico, M.; Verstuyft, C.; Dubert, L.; Becquemont, L.; Guiochon-Mantel, A.; Scarabin, P. Y.. Clin Pharmacol Ther.. 2011; 60-4: p.60-4Article